We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-1.89%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$48.4B
AUM Growth
+$1.38B
(+2.9%)
Cap. Flow
+$2.75B
Cap. Flow
% of AUM
5.68%
Top 10 Holdings %
Top 10 Hldgs %
14.42%
Holding
2,432
New
254
Increased
1,140
Reduced
904
Closed
123
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hawaiian Electric Industries
HE
|
+$139M |
| 2 |
GE Aerospace
GE
|
+$128M |
| 3 |
NVIDIA
NVDA
|
+$100M |
| 4 |
Citizens Financial Group
CFG
|
+$99M |
| 5 |
Molson Coors Class B
TAP
|
+$97.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CF Industries
CF
|
+$89.6M |
| 2 |
Booking.com
BKNG
|
+$82.6M |
| 3 |
Domino's
DPZ
|
+$81.9M |
| 4 |
Apple
AAPL
|
+$81.9M |
| 5 |
American International
AIG
|
+$75.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.29% |
| 2 | Healthcare | 13.45% |
| 3 | Consumer Discretionary | 13.42% |
| 4 | Industrials | 12.23% |
| 5 | Financials | 11.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Dyne Therapeutics
DYN
$4.95B
| $104K | ﹤0.01% |
11,644
-8,525
| -42% | -$91.8K |
|
2227
Omeros
OMER
$986M
| $104K | ﹤0.01% |
+35,565
| New | +$143K |
|
|
AVDX
2228
DELISTED
AvidXchange
AVDX
| $103K | ﹤0.01% |
+10,880
| New | +$114K |
|
2229
Adicet Bio
ACET
$75.9M
| $103K | ﹤0.01% |
+4,689
| New | +$166K |
|
2230
TAL Education Group
TAL
$6.93B
| $100K | ﹤0.01% |
+11,010
| New | +$77.2K |
|
|
LUCK
2231
Lucky Strike Entertainment
LUCK
$893M
| $99.8K | ﹤0.01% |
10,371
-21,741
| -68% | -$239K |
|
|
UDMY
2232
DELISTED
Udemy
UDMY
| $97.1K | ﹤0.01% |
+10,221
| New | +$107K |
|
2233
OptimizeRx
OPRX
$129M
| $96.1K | ﹤0.01% |
+12,355
| New | +$134K |
|
2234
Comtech Telecommunications
CMTL
$51.5M
| $95.7K | ﹤0.01% |
+10,932
| New | +$102K |
|
|
ATXS
2235
DELISTED
Astria Therapeutics
ATXS
| $95.4K | ﹤0.01% |
+12,790
| New | +$109K |
|
|
SRG
2236
Seritage Growth Properties
SRG
$136M
| $95K | ﹤0.01% |
+12,274
| New | +$103K |
|
2237
Universal Technical Institute
UTI
$1.47B
| $93.1K | ﹤0.01% |
11,107
-85,412
| -88% | -$665K |
|
2238
Atea Pharmaceuticals
AVIR
$402M
| $91.1K | ﹤0.01% |
30,353
-3,237
| -10% | -$11K |
|
2239
PMV Pharmaceuticals
PMVP
$65.6M
| $89.7K | ﹤0.01% |
14,611
-9,056
| -38% | -$62.3K |
|
2240
Vera Bradley
VRA
$96.4M
| $86.5K | ﹤0.01% |
+13,079
| New | +$86.7K |
|
|
TERN
2241
DELISTED
Terns Pharmaceuticals
TERN
| $85.6K | ﹤0.01% |
17,014
-1,049
| -6% | -$6.66K |
|
2242
Algonquin Power & Utilities
AQN
$4.36B
| $85.5K | ﹤0.01% |
+14,438
| New | +$109K |
|
2243
Verrica Pharmaceuticals
VRCA
$88M
| $85.3K | ﹤0.01% |
+2,197
| New | +$112K |
|
|
SLGC
2244
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $84.5K | ﹤0.01% |
+35,356
| New | +$78.3K |
|
|
TIO
2245
DELISTED
Tingo Group, Inc. Common Stock
TIO
| $84.3K | ﹤0.01% |
+82,274
| New | +$104K |
|
|
INZY
2246
DELISTED
Inozyme Pharma
INZY
| $82.9K | ﹤0.01% |
+19,744
| New | +$100K |
|
|
BIG
2247
DELISTED
Big Lots, Inc.
BIG
| $82.7K | ﹤0.01% |
16,178
+4,695
| +41% | +$35.7K |
|
2248
Sutro Biopharma
STRO
$423M
| $82.4K | ﹤0.01% |
2,376
-5,794
| -71% | -$252K |
|
2249
Arbutus Biopharma
ABUS
$907M
| $82.4K | ﹤0.01% |
40,598
+26,075
| +180% | +$54.7K |
|
|
PGRE
2250
DELISTED
Paramount Group
PGRE
| $81.5K | ﹤0.01% |
17,633
-113,304
| -87% | -$560K |
|
Similar funds
VGA
AQR Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, AQR Capital Management held 2,432 positions worth $48.4B, up 2.9% from $47B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management deployed $2.75B of net new capital in Q3 2023, opening 254 new positions and adding to 1,140 existing holdings. Its largest new stake was Vanguard FTSE Developed Markets ETF: 624,491 shares worth $27.3M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was CF Industries, an estimated $89.6M trimmed.
- AQR Capital Management's largest Q3 2023 buy was Vanguard FTSE Developed Markets ETF: 624,491 shares worth $27.3M.
- AQR Capital Management added most to Hawaiian Electric Industries in Q3 2023, an estimated $139M increase.
- AQR Capital Management's biggest Q3 2023 reduction was CF Industries, cutting an estimated $89.6M.
- AQR Capital Management fully exited Univar Solutions Inc. in Q3 2023, selling an estimated $60.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $48.4B portfolio in Q3 2023.
- AQR Capital Management opened 254 new positions and closed 123 in Q3 2023.
- AQR Capital Management's portfolio value rose 2.9% quarter-over-quarter to $48.4B.
Based on AQR Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.